BEIJING: Chinese authorities summoned officers of AstraZeneca China relating to an investigation of suspected medical insurance coverage fraud by the corporate’s workers, the National Healthcare Security Administration (NHSA) mentioned on Saturday (Jan 29).
The regulator of the state medical insurance coverage fund mentioned authorities ordered the arrest of all suspects however didn’t give particulars of the suspected violations or the dimensions of funds concerned.
It demanded that AstraZeneca China shut loopholes in supervision of selling actions, the NHSA added.
In a press release on Friday, the corporate mentioned some workers within the southern metropolis of Shenzhen had altered or participated in altering sufferers’ testing reviews, and had been suspected of medical insurance coverage fraud.
The NHSA and public safety ministry held a gathering with firm officers in December to transient them on the investigation, it added.
“AstraZeneca China takes such employee misconduct seriously and welcomes the recommendations by the NHSA and MOPS,” it mentioned.
An AstraZeneca spokesperson mentioned all workers concerned within the Shenzhen case had been Chinese nationals.
The firm has taken disciplinary motion towards these workers and has reported their violations to the authorities, the assertion mentioned.
Authorities will launch nationwide campaigns to stamp out fraud that entails altering genetic check outcomes, the NHSA added, urging these liable for such violations to show themselves in.